RBM4 promotes pancreas cell differentiation and insulin expression

Molecular and Cellular Biology

Volumn 33, Issue 2, 2013, Pages 319-327

  Lin, Jung Chun ^a,b   Yan, Yu Ting ^a   Hsieh, Wen Kou ^a   Peng, Pey Jey ^a   Su, Chun Hao ^a,c   Tarna, Woan Yuh ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; RNA BINDING MOTIF PROTEIN 4; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ISL1; TRANSCRIPTION FACTOR PAX4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE METABOLISM; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS CELL; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING;

ALTERNATIVE SPLICING; ANIMALS; CELL DIFFERENTIATION; EXONS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; INSULIN; ISLETS OF LANGERHANS; LIM-HOMEODOMAIN PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MUSCLES; PAIRED BOX TRANSCRIPTION FACTORS; PROTEIN ISOFORMS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

MUS;

EID: 84871884739     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01266-12     Document Type: Article

References (33)

1. Hribal ML, Perego L, Lovari S, Andreozzi F, Menghini R, Perego C, Finzi G, Usellini L, Placidi C, Capella C, Guzzi V, Lauro D, Bertuzzi F, Davalli A, Pozza G, Pontiroli A, Federici M, Lauro R, Brunetti A, Folli F, Sesti G. 2003. Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans. FASEB J. 17:1340-1342.
2. Khoo S, Cobb MH. 1997. Activation of mitogen-activating protein kinase by glucose is not required for insulin secretion. Proc. Natl. Acad. Sci. U. S. A. 94:5599-5604.
3. Heyd F, Lynch KW. 2011. Degrade, move, regroup: signaling control of splicing proteins. Trends Biochem. Sci. 36:397- 404.
4. Lin JC, Tarn WY. 2012. Multiple roles of RBM4 in muscle cell differentiation. Front. Biosci. (Schol Ed) 4:181-189.
5. Moroy T, Heyd F. 2007. The impact of alternative splicing in vivo: mouse models show the way. RNA 13:1155-1171.
6. Xu X, Yang D, Ding JH, Wang W, Chu PH, Dalton ND, Wang HY, Bermingham Jr, Ye Z, Liu F, Rosenfeld MG, Manley JL, Ross J, Jr, Chen J, Xiao RP, Cheng H, Fu XD. 2005. ASF/SF2-regulated CaMKII delta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120:59-72.
7. Kozmik Z, Czerny T, Busslinger M. 1997. Alternatively spliced insertions in the paired domain restrict the DNA sequence specificity of Pax6 and Pax8. EMBO J. 16:6793- 6803.
8. Reichert M, Rustgi AK. 2011. Pancreatic ductal cells in development, regeneration, and neoplasia. J. Clin. Invest. 121:4572- 4578.
9. Ando K, Shioda S, Handa H, Kataoka K. 2003. Isolation and characterization of an alternatively spliced variant of transcription factor Islet-1. J. Mol. Endocrinol. 31:419-425.
10. Kuroda A, Rauch TA, Todorov I, Ku HT, Al-Abdullah IH, Kandeel F, Mullen Y, Pfeifer GP, Ferreri K. 2009. Insulin gene expression is regulated by DNA methylation. PLoS One 4:e6953. doi:10.1371/journal.pone.0036278. 11. Miyamoto T, Kakizawa T, Ichikawa K, Nishio S, Kajikawa S, Hashizume K. 2001. Expression of dominant negative form of PAX4 in human insulinoma. Biochem. Biophys. Res. Commun. 282:34-40.
11. Miyamoto T, Kakizawa T, Ichikawa K, Nishio S, Kajikawa S, Hashizume K. 2001. Expression of dominant negative form of PAX4 in human insulinoma. Biochem. Biophys. Res. Commun. 282:34-40.
12. Liu P, Jenkins NA, Copeland NG. 2003. A highly efficient recombineering- based method for generating conditional knockout mutations. Genome Res. 13:476-484.
13. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62- 66.
14. Vintersten K, Monetti C, Gertsenstein M, Zhang P, Laszlo L, Biechele S, Nagy A. 2004. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos and adult animals. Genesis 40:241-246.
15. Nagy A, Gertsenstein M, Vintersten K, Behringer R. 2003. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
16. O'Doherty RM, Jensen PB, Anderson P, Jones JG, Berman HK, Kearney D, Newgard CB. 2000. Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen. J. Clin. Invest. 105:479-488.
17. Samuelson LC, Metzger JM. 2006. Isolation and freezing of primary mouse embryonic fibroblasts (MEF) for feeder plates. Cold Spring Harb. Protoc. doi:10.1101/pdb.prot4482.
18. Lin JC, Tarn WY. 2011. RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing. J. Cell Biol. 193:509- 520.
19. Giudice J, Leskow FC, Arndt-Jovin DJ, Jovin TM, Jares-Erijman EA. 2011. Differential endocytosis and signaling dynamics of insulin receptor variants IR-A and IR-B. J. Cell Sci. 124:801- 811.
20. Barr FG, Fitzgerald JC, Ginsberg JP, Vanella ML, Davis RJ, Bennicelli JL. 1999. Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines. Cancer Res. 59:5443-5448.
21. Ogihara T, Fujitani Y, Uchida T, Kanno R, Choi JB, Hirose T, Kawamori R, Watada H. 2008. Combined expression of transcription factors induces AR42J-B13 cells to differentiate into insulin-producing cells. Endocr. J. 55:691- 698.
22. Santer R, Groth S, Kinner M, Dombrowski A, Berry GT, Brodehl J, Leonard JV, Moses S, Norgren S, Skovby F, Schneppenheim R, Steinmann B, Schaub J. 2002. The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome. Hum. Genet. 110:21-29.
23. Melloul D, Marshak S, Cerasi E. 2002. Regulation of insulin gene transcription. Diabetologia 45:309-326.
24. Leibiger B, Moede T, Uhles S, Barker CJ, Creveaux M, Domin J, Berggren PO, Leibiger IB. 2010. Insulin-feedback via PI3K-C2alpha activated PKBalpha/Akt1 is required for glucose-stimulated insulin secretion. FASEB J. 24:1824-1837.
25. Kalsotra A, Cooper TA. 2011. Functional consequences of developmentally regulated alternative splicing. Nat. Rev. Genet. 12:715-729.
26. Elghazi L, Bernal-Mizrachi E. 2009. Akt and PTEN: beta-cell mass and pancreas plasticity. Trends Endocrinol. Metab. 20:243-251.
27. Knudsen L, De Meyts P, Kiselyov VV. 2011. Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms. Biochem. J. 440:397- 403.
28. Lin JC, Tarn WY. 2005. Exon selection in alpha-tropomyosin mRNA is regulated by the antagonistic action of RBM4 and PTB. Mol. Cell. Biol. 25:10111-10121.
29. Sumara G, Formentini I, Collins S, Sumara I, Windak R, Bodenmiller B, Ramracheya R, Caille D, Jiang H, Platt KA, Meda P, Aebersold R, Rorsman P, Ricci R. 2009. Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Cell 136:235-248.
30. Kordowich S, Mansouri A, Collombat P. 2010. Reprogramming into pancreatic endocrine cells based on developmental cues. Mol. Cell. Endocrinol. 323:62- 69.
31. Orengo JP, Ward AJ, Cooper TA. 2011. Alternative splicing dysregulation secondary to skeletal muscle regeneration. Ann. Neurol. 69:681- 690.
32. Raj B, O'Hanlon D, Vessey JP, Pan Q, Ray D, Buckley NJ, Miller FD, Blencowe BJ. 2011. Cross-regulation between an alternative splicing activator and a transcription repressor controls neurogenesis. Mol. Cell 43: 843-850.
33. Evans-Molina C, Garmey JC, Ketchum R, Brayman KL, Deng S, Mirmira RG. 2007. Glucose regulation of insulin gene transcription and pre-mRNA processing in human islets. Diabetes 56:827- 835.